Rare Disease Biotech Offers Access Ahead of Key Milestone

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Kroger Co
NYSE:KR
$67.41

Financials

Curr Year EPS Estimate4.46
Profit Margin1.84%
Operating Margin3.18
Return on Assets0.06
Return on Equity0.25
Revenue147B
Earnings Per Share4
Revenue Per Share214.76
Gross Profit35,155,001,344
Quarterly Revenue Growth0.00

General

NameKroger Co
TickerKR
ExchangeNYSE
SectorConsumer Defensive
IndustryGrocery Stores
CurrencyUSD
CountryUSA
Fiscal Year EndJanuary
Full Time Employees400,000

About Kroger Co

The Kroger Co. operates as a food and drug retailer in the United States. The company operates combination food and drug stores, multi-department stores, marketplace stores, and price impact warehouses. Its combination food and drug stores offer natural food and organic sections, pharmacies, general merchandise, pet centers, fresh seafood, and organic produce; and its multi-department stores provide apparel, home fashion and furnishings, outdoor living, electronics, automotive products, and toys. The company's marketplace stores offer full-service grocery, pharmacy, health and beauty care, and perishable goods, as well as general merchandise, including apparel, home goods, and toys; and its price impact warehouse stores provide grocery, and health and beauty care items, as well as meat, dairy, baked goods, and fresh produce items. It also manufactures and processes food products for sale in its supermarkets and online; and sells fuel through its fuel centers. The company sells its products through its stores, fuel centers, and online platforms. The Kroger Co. was founded in 1883 and is based in Cincinnati, Ohio.

Dividend

Kroger Co pays out a dividend of $1.34 per share, with a dividend yield of 1.99%.

KR's next dividend payment will be made to shareholders on December 1, 2025.

They pay out 34.03% of their earnings out as a dividend.

Recent Dividends

Dec 1, 2025$0.35
Sep 1, 2025$0.35
Jun 1, 2025$0.32
Mar 1, 2025$0.32
Dec 1, 2024$0.32
Sep 1, 2024$0.32
Jun 1, 2024$0.29
Mar 1, 2024$0.29
Dec 1, 2023$0.29
Popular

Is Supermicro Stock The AI Winner Everyone's Overlooking?

Super Micro Computer Inc (SMCI) is seeing a surge in stock value after announcing global volume shipments of its Nvidia Corp (NVDA) Blackwell Ultra-powered systems for AI workloads.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Europe's Ryder Cup team uses VR headsets to prepare for noise and insults at Bethpage Black

VIRGINIA WATER, England (AP) — Whatever heckling European players might face at the Ryder Cup in New York could be what they already have heard before, all because of virtual reality headsets that Rory McIlroy says can be adjusted to hear the harshest abuse.

Enovix Stock Tumbles After Hours: What To Know

Enovix shares are down after the company announced the offering of $300 million in convertible senior notes.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Judge Tosses Trump's $15 Billion Case Against New York Times, President Claims He's 'Winning'

A federal judge dismissed Trump's $15 billion defamation lawsuit against The New York Times, calling it "decidedly improper," but gave him 28 days to resubmit it with a 40-page limit.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area

Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Lithuanian prosecutors allege Russia-linked network planned arson attacks in Europe

VILNIUS, Lithuania (AP) — Lithuanian prosecutors said they uncovered a who are alleged to have planned and organized arson attacks in various European countries.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Long-wrought WTO agreement aimed at reducing overfishing takes effect

GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.

"The America You Knew Is Dying in Front of You" - Ad

That's the urgent warning the former $200 million hedge fund firm manager who predicted 2008 and 2020 just issued. He says if you're over 50, there's one urgent move you need to make to survive... or risk getting left behind. The rules are changing:

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

A jury will look at whether Amazon tricked customers into joining Prime -- and made it hard to leave

SEATTLE (AP) — A federal trial beginning in Amazon's hometown this week is set to examine whether the online retailing giant tricked customers into signing up for its Prime service and made it difficult to cancel after they did so.

Taiwan Semiconductor To Strengthen Chipmaking Network With Pingtung Service Hub

TSM to launch multifunctional service center in Taiwan to boost high-tech facility construction. Stock up 31% YTD.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Ukraine expects $3.5 billion fund for US weapons to sustain fight against Russia, Zelenskyy says

KYIV, Ukraine (AP) — Ukraine expects there will be around $3.5 billion by next month in a fund to buy weapons from the United States and help sustain its against Russia’s all-out invasion, Ukrainian President Volodymyr Zelenskyy said Wednesday.

Elon Musk And Sam Altman May Not Agree On Everything, But On This One Topic Their Ideas Align

OpenAI CEO Sam Altman sparked debate by saying society was "better off with phone call culture," echoing other tech leaders and research showing most meetings kill productivity.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Trump's plan for a drug advertising crackdown faces many hurdles

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.

Family says a man who died after going on a Universal roller coaster never let wheelchair stop him

ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

New England's shrimp industry is struggling, with fishermen catching few in 2025

PORTLAND, Maine (AP) — There's an effort underway to bring New England shrimp back to seafood customers — but fishermen have found few of the crustaceans, and the fishing industry that harvests them may face an even longer shutdown.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service